Inspecs GroupINPEF 52 Pretax Margin % is -2.76% as of Dec. 2025. GuruFocus rates INPEF with a GF Score™ of 52/100 and a GF Value™ of $0.65. The stock has 6 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Inspecs Group ranks worse than 53.73% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Inspecs Group's Pre-Tax Income for the
six
months ended in Dec. 2025 was $-3.5 Mil. Inspecs Group's Revenue for the
six
months ended in Dec. 2025 was $125.9 Mil. Therefore, Inspecs Group's pretax margin for the quarter that ended in Dec. 2025 was -2.76%.
The historical rank and industry rank for Inspecs Group's Pretax Margin % or its related term are showing as below:
INPEF'
s Pretax Margin % Range Over the Past 10 Years
Min: -23.54 Med: -0.01 Max: 11.99
Current: -0.13
INPEF's Pretax Margin % is ranked worse than 53.73% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.61
vs INPEF: -0.13
Inspecs Group (OTCPK:INPEF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Inspecs Group Pretax Margin % Related Terms
Inspecs Group Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Inspecs Group's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INPEF vs ISRG, BDX, MDLN: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, Inspecs Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspecs Group Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspecs Group's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Inspecs Group's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspecs Group (INPEF) has a Pretax Margin % of -2.76% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Inspecs Group and its competitors. According to the industry distribution chart, Inspecs Group ranks #439 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 53.7%.
Is Inspecs Group's Pretax Margin % too high?
Inspecs Group's current Pretax Margin % is -2.76%. Based on the distribution chart, Inspecs Group ranks #439 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Inspecs Group has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Inspecs Group's Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Inspecs Group ranks #439 out of 817 companies for Pretax Margin %. This places Inspecs Group in the lower half of its industry. The industry median Pretax Margin % is 2.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.61, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Inspecs Group and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspecs Group's current Pretax Margin % is -2.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspecs Group stock overvalued right now?
Inspecs Group (INPEF) has a current Pretax Margin % of -2.76%. The stock's GF Value™ is $0.65, compared to a current price of $1.08 — trading 66.2% above its estimated fair value. The current Pretax Margin % is -2.76%. Inspecs Group's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Inspecs Group (INPEF), the current Pretax Margin % is -2.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspecs Group (INPEF) Overvalued in 2026?
Based on GuruFocus' analysis, Inspecs Group stock appears to be overvalued.
The current stock price of $1.08 is trading 66.2% above its estimated GF Value™ of $0.65.
Key valuation signals for INPEF:
Pretax Margin %: -2.76%
GF Value™: $0.65 vs. price of $1.08 (66.2% above fair value)
No single metric tells the full story. See the INPEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspecs Group PLC is a designer and manufacturer of eyewear frames and accessories. The customers of the company include optical and Non-optical retailers, distributors, and independent opticians. The company operations are spread across the United Kingdom, Europe (excluding the UK), South America, North America, Asia, Africa, and Australia. Its eyewear brands include Superdry, Titanflex, O'Neill, Brendel, Humphreys, Marc O'Polo, and among others. The reporting segments of the company are Frames and Optics product distribution which derives maximum revenue, and Manufacturing includes OEM and manufacturing distribution segment.
52GF Score
Get the complete analysis for INPEF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INPEF has been successfully added to your 
